You searched for - Page 53 of 141 - KFF Health News

If High Court Reverses Roe V. Wade, 22 States Poised To Ban Abortion

By Julie Rovner July 10, 2018 KFF Health News Original

As with current abortion policies, a woman’s access to the procedure would continue to be determined by where she lives.

Hospitals Score Victory As Judge Rules That Administration’s Cuts To 340B Program Overstepped Authority

January 2, 2019 Morning Briefing

The hospital groups fighting the Trump administration’s change to the 340B drug discount program said that the cuts impeded their ability to provide care for low-income patients. In his opinion, Judge Rudolph Contreras said that, while the HHS secretary does have the authority to make “adjustments” to the program, “he cannot fundamentally rework the statutory scheme.”

State Pay Cut For Dental Hygienists Who Serve The Poor Was Illegal, Court Finds

By Ana B. Ibarra March 2, 2018 KFF Health News Original

California officials should have obtained federal approval before they cut reimbursement rates for dental hygienists who serve frail Californians living in nursing homes and board-and-care facilities, a judge has ruled.

Outrageous Or Overblown? HHS Announces Another Round Of ACA Navigator Funding Cuts

By Phil Galewitz July 12, 2018 KFF Health News Original

Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.

With Some Republican Support, Virginia Edges Closer To Medicaid Expansion

By Megan Pauly, WCVE March 16, 2018 KFF Health News Original

More than a dozen Republicans in the Virginia House of Delegates voted to expand Medicaid, and at least one state senator may be leaning in favor of expansion. It will be the hot topic as legislators are called back to Richmond to hash out a budget in the special session starting April 11.

Podcast: KHN’s ‘What The Health?’ Health Law Fix Misses The Spending Bill Train

March 23, 2018 KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

Scrutinizing Medicare Coverage For Physical, Occupational And Speech Therapy

By Judith Graham March 29, 2018 KFF Health News Original

Treatment has been terminated for some seniors because therapists told them they weren’t making enough progress or that they had reached their annual limit. We examine the treatment benefits and the barriers under Medicare’s coverage rules for therapy.

Listen: Got A Sky-High Bill? Don’t Write The Check.

February 16, 2018 KFF Health News Original

Have you gotten a medical bill that sounds way too expensive or is just downright confusing? Send it to us. KHN Editor-in-Chief Elisabeth Rosenthal talks with NPR Morning Edition Host Steve Inskeep about the launch of “Bill Of The Month,” KHN and NPR’s new crowdsourced investigation.

Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change

By Sarah Jane Tribble and Liz Szabo May 11, 2018 KFF Health News Original

President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.

Poison Ivy, A ‘Familiar Stranger’ That Could Ruin Your Summer

By Blake Farmer, Nashville Public Radio June 11, 2018 KFF Health News Original

Spotting poison ivy is tricky because it can come in several forms. And bad rashes may need to be treated by a doctor. Warning: This story might make you itch.

How A Drug Company Under Pressure For High Prices Ratchets Up Political Activity

By Jay Hancock and Elizabeth Lucas April 30, 2018 KFF Health News Original

Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.

California Takes On Health Giant Over High Costs

By Chad Terhune and Ana B. Ibarra April 1, 2018 KFF Health News Original

The lawsuit is a bold move against Northern California’s dominant hospital chain, whose prices have drawn complaints for years. It has disputed such allegations in the past.

Impact Of Drug Prices In TV Ads Mitigated If Consumers Think They Could Be Eligible For Free Treatment

January 24, 2019 Morning Briefing

A new study looked at the effectiveness of the Trump administration’s proposal to require drugmakers to state prices in TV commercials. While putting the costs in did affect consumers, the impact was muted if the ad’s language suggests that some people could get the treatment for free. In other pharmaceutical news: foreign drug pricing, the controversial 340B program, negotiating powers for Medicaid, and more.

Despite GOP Losing Control Of The House, Anti-Abortion Advocates Aren’t Worried About Movement’s Momentum

January 9, 2019 Morning Briefing

With Justice Brett Kavanaugh on the court, the anti-abortion movement is eager to see cases move through the judicial branch. “Our agenda is very focused on the executive branch, the coming election, and the courts,” said Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List. Abortion news comes out of Louisiana, as well.

Bristol-Meyers Announces $74B Merger With Celgene In Deal Primed To Have Sweeping Implications For Drug Industry

January 4, 2019 Morning Briefing

In the first major pharmaceutical deal of 2019, Bristol-Myers Squibb says it will buy Celgene, a maker of cancer-fighting drugs, in a merger valued at $74 billion. According to Stat, Bristol-Myers has been under pressure to set a new course since August 2016, when a big study of its cancer immunotherapy, Opdivo, failed to show a benefit in previously untreated patients with non-small cell lung cancer. Analysts look at what the deal means to the industry at large.

Older Americans Are Hooked On Vitamins Despite Scarce Evidence They Work

By Liz Szabo April 4, 2018 KFF Health News Original

Sixty-eight percent of those 65 and older take vitamin supplements. Much of what we once believed about the benefits is wrong.

‘Aggressive’ New Advance Directive Would Let Dementia Patients Refuse Food

By JoNel Aleccia March 30, 2018 KFF Health News Original

Supporters call it the strongest move yet to document a patient’s advance wishes in cases of severe dementia. Critics say it would deny basic care to society’s most vulnerable.

In Weary Post-Storm Puerto Rico, Medicaid Cutbacks Bode New Ills

By Sarah Varney and Carmen Heredia Rodriguez August 6, 2018 KFF Health News Original

The island’s government must squeeze $840.2 million in annual savings from Medicaid by 2023, part of the U.S. territory’s agreement with the federal government as Puerto Rico claws its way back from fiscal oblivion. Experts warn such drastic cuts defy actuarial science.

Drug Giant Eli Lilly To Purchase Tiny Startup In $8B Deal To Get Access To Company’s Cancer Treatments

January 8, 2019 Morning Briefing

The purchase could be very lucrative for Eli Lilly. Loxo Oncology’s drug Vitrakvi was approved by the FDA recently based on evidence that it can shrink tumors in 75 percent of patients whose cancer tests positive for a particular kind of genetic mutation.

In A Puerto Rican Mountain Town, Hope Ebbs And Health Suffers

By Sarah Varney April 19, 2018 KFF Health News Original

More than six months after Hurricane Maria, daily life in Castañer, Puerto Rico, is nowhere close to normal as residents try to deal with the effects of trauma, chronic stress and the continued lack of electricity.

Filter Results

More From KFF Health News